POLICY STATEMENT

Red Reflex Examination in Neonates, Infants and Children

Organizational Principles to Guide and Define the Child Health Care System and/or Improve
the Health of All Children

A joint statement of the American Academy of Pediatrics (Section on Ophthalmology), the

American Association for Pediatric Ophthalmology and Strabismus, the American Academy
of Ophthalmology and the American Association of Certified Orthoptists.

Abstract:
Red reflex testing is an essential component of the neonatal, infant, and child physical
examination. This statement, which is a revision of the previous policy statement published
in 2002, describes the rationale for testing, the technique used to perform this examination,
and the indications for referral to an ophthalmologist experienced in the examination of
children.

Key words: red reflex testing, Bruckner reflex, vision screening.

Introduction:
Red reflex testing is vital for early detection of vision- and potentially life-threatening
abnormalities, such as cataracts, glaucoma, retinoblastoma, retinal abnormalities, systemic
diseases with ocular manifestations, and high refractive errors. The American Academy of
Pediatrics currently recommends red reflex assessment as a component of the eye
evaluation in the neonatal period and during all subsequent routine health supervision
visits1 (see also Bright Futures, available at www.brightfutures.org).

The red reflex test uses transmission of light from an ophthalmoscope through all the
normally transparent parts of a subject’s eye, including the tear film, cornea, aqueous
humor, crystalline lens, and vitreous humor. This light reflects off the ocular fundus and is
transmitted back through the optical media and through the aperture of the
ophthalmoscope, and is imaged in the eye of the examiner. Any factor that impedes or
blocks this optical pathway will result in an abnormality of the red reflex. An abnormal red
reflex can result from mucous or other foreign bodies in the tear film, corneal opacities,
aqueous opacities, iris abnormalities affecting the pupillary aperture (pupil), cataracts,
vitreous opacities, and retinal abnormalities including tumors or chorioretinal colobomata.
Unequal or high refractive errors (need for glasses) and strabismus (eye misalignment) may
also produce abnormalities or asymmetry of the red reflex. There may be significant
variation in the red reflex in children from different racial or ethnic groups resulting from
their differing levels of pigmentation of the ocular fundus. Nevertheless, the pediatrician
who performs these evaluations on a regular basis will quickly become familiar with these
variations in normalcy.

1
Performing the Red Reflex Test:
The red reflex test is properly performed by holding a direct ophthalmoscope close to the
examiner’s eye with the ophthalmoscope lens power set at “0” (see Fig 1). In a darkened
room, the ophthalmoscope light should then be projected onto both eyes of the child
simultaneously from approximately 18 inches away. To be considered normal, a red reflex
should emanate from both eyes and be symmetric in character. Dark spots in the red reflex,
a markedly diminished reflex, the presence of a white reflex, or asymmetry of the reflexes
(Bruckner reflex) are all indications for referral to an ophthalmologist experienced in the
examination of children. The exception to this rule is a transient opacity from mucous in the
tear film that is mobile and completely disappears with blinking.

All infants and children with a positive family history of retinoblastoma; congenital, infantile,
or juvenile cataracts; glaucoma; or retinal abnormalities should be referred to an
ophthalmologist experienced in the examination of children for a complete eye examination
regardless of the status of the red reflex, because these children are at high risk of vision-
and potentially life-threatening eye abnormalities. Age of referral to an ophthalmologist
depends on specific risk factors (eg, genetic condition, familial eye disease, etc), which can
vary in age of presentation. However, it is still valuable for the pediatrician to perform red
reflex testing on these patients to help determine if it is necessary to expedite this referral.
Whenever an opacity or tumor is suspected, an expedited referral is indicated. Because of
the urgent nature of diagnosis, it is prudent for the pediatrician to contact the
ophthalmologist personally about the possible diagnosis and express (and document) the
urgency of the appointment to the parent. It is also essential that the ophthalmologist follow
up with patients, send timely reports to primary care physicians, and make sure that the
transfer of care back to the referring physician is clean and understood by all parties.

The purpose of this policy statement, which is a revision of the previous statement
published in 2002,2 is to suggest a policy based on current knowledge and experience for
examination of the eyes of neonates, infants, and children to minimize the risk of delay in
diagnosis of serious vision-threatening or life-threatening disorders.

Occasionally, some pediatricians find that red reflex testing can be facilitated by dilating the
eyes of the subject. Although in infants, pupils are easily dilated by using various agents,
significant complications sporadically have been reported with all commercially available
dilating eye drops, including sympathomimetic agents, such as phenylephrine, and
anticholinergic agents, such as cyclopentolate hydrochloride and tropicamide. These
complications include elevated blood pressure and heart rate, 3 urticaria,4 cardiac
arrhythmias,5 and contact dermatitis.6,7 However, pupillary dilation has been performed
routinely for many years in almost all new patients seen by pediatric ophthalmologists, with
a very low incidence of toxicity. Hence, this procedure appears to be safe when performed
in an office setting on infants older than 2 weeks. Nevertheless, to minimize liability
exposure, physicians should discuss with the parents the nature and purpose of the
proposed diagnostic procedure and any potential risks associated with the procedure or
accompanying medications, including but not limited to pain, discomfort, bradycardia,
respiratory depression, and hypertension, and document the provision of this information in
the medical record. Such informed-consent precautions are particularly important when
testing preterm infants. Preterm infants seem to be particularly sensitive to the adverse
effects of mydriatic eye drops; consequently, the concentration of these pharmacologic
agents should be reduced.8

2
Suggested Eyedrops for Dilation in Infants:
For infants younger than 9 months:

A combination drop of 0.25% cylopentolate with 2.5% phenylephrine (Cyclomydril

[Alcon Laboratories, Fort Worth, TX]) approximately 15 minutes before examination.
Note that atropine drops should be avoided in young infants because of the potential
for anticholinergic adverse effects.

For infants older than 9 months:

Tropicamide 1%, phenylephrine 2.5% ophthalmic drops; give 1 drop of either or

both approximately 15 minutes before red reflex testing.

A combination drop of 0.25% cyclopentolate with 2.5% phenylephrine (Cyclomydril)

approximately 15 minutes before examination.

Recommendations:
All neonates, infants, and children should have an examination of the red reflex of the
eyes performed by a pediatrician or other primary care clinician trained in this
examination technique before discharge from the neonatal nursery and during all
subsequent routine health supervision visits.
The result of the red reflex examination is to be rated as normal when the reflections of
the 2 eyes viewed both individually and simultaneously are equivalent in color, intensity,
and clarity and there are no opacities or white spots (leukokoria) within the area of
either or both red reflexes.
All infants or children with an abnormal Bruckner reflex or absent red reflex should be
referred immediately to an ophthalmologist who is skilled in pediatric examinations.

It is essential that the referring practitioner communicate the abnormal findings directly
with the ophthalmologist and receive confirmation back from the ophthalmologist that
proper follow-up consultation was performed.

Infants or children in high-risk categories, including relatives of patients with

retinoblastoma, infantile or juvenile cataracts, retinal dysplasia, glaucoma, or other
vision-threatening ocular disorders that can present in infancy, should not only have red
reflex testing performed in the nursery but also be referred to an ophthalmologist who is
experienced in examining children for a complete eye examination regardless of the
findings of the red reflex testing by the pediatrician.
Infants or children in whom parents or other observers describe a history suspicious for
the presence of leukokoria (a white pupil reflex) in one or both eyes should be examined
by an ophthalmologist who is experienced in the examination of children, because small
retinoblastoma tumors or other serious lesions may present in a subtle fashion.

Section on Ophthalmology, 2005-2006

Edward J. Buckley, MD, Chairperson
George S. Ellis, Jr, MD, Chairperson-Elect
Stephen Glaser, MD
David Granet, MD
Jane D. Kivlin, MD
Gregg T. Lueder, MD
*James B. Ruben, MD

3
Maynard B. Wheeler, MD

Immediate Past Chairperson

Steven J. Lichtenstein, MD

Liaisons
Kyle A. Arnoldi, CO
American Association of Certified Orthoptists
Christie L. Morse, MD
American Academy of Ophthalmology
Michael X. Repka, MD
American Association for Pediatric Ophthalmology and Strabismus

Staff
S. Niccole Alexander, MPP

* Lead Author

REFERENCES

1. American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine,

Section on Ophthalmology; American Association of Certified Orthopedists; American
Association for Pediatric Ophthalmology and Strabismus; American Academy of
Ophthalmology. Eye examination in infants, children, and young adults by
pediatricians. Pediatrics. 2003;111(4 pt 1):902-907
2. American Academy of Pediatrics, Section on Ophthalmology. Red reflex examination
in infants and children. Pediatrics. 2002;109(5):980-981
3. Oğüt MS, Bozkurt N, Ozek E, Birgen H, Kazokoğlú H, Oğüt M. Effects and side effects
of mydriatic eyedrops in neonates. Eur J Ophthalmol. 1996;6(2):192-196
4. Fraunfelder FT. Pupil dilation using phenylephrine alone or in combination with
tropicamide. Ophthalmology. 1999;106(1):4
5. Gaynes BI. Monitoring drug safety: cardiac events in routine mydriasis. Optom Vis
Sci. 1998;75(4):245-246
6. Resano A, Esteve C, Fernandez Benitez M. Allergic contact blepharoconjunctivitis due
to phenylephrine eye drops. J Investig Allergol Clin Immunol. 1999;9(1):55-57
7. Boukhman MP, Maibach HI. Allergic contact dermatitis from tropicamide ophthalmic
solution. Contact Dermatitis. 1999;41(1):47-48
8. Chew C. Rahman RA, Shafie SM, Mohamad Z. Comparison of mydriatic regimens
used in screening for retinopathy of prematurity in preterm infants with dark irides. J
Pediatr Ophthamol Strabismus. 2005;42(3):166-173

Approved by: American Academy of Pediatrics, 2002

Revised and Approved by: American Academy of Ophthalmology, 2008

American Academy of Pediatrics, 2008
American Association for Pediatric Ophthalmology and

4
 Strabismus, 2008
American Association of Certified Orthoptists, 2008

© 2008 American Academy of Ophthalmology®

P.O. Box 7424 / San Francisco, CA 94109 / 415.561.8500

American Academy of Pediatrics

141 Northwest Point Blvd. / Elk Grove Village, IL 60007 / 847-434-4000

American Association for Pediatric Ophthalmology and Strabismus

P.O. Box 193832 / San Francisco, CA 94119-3832 / 415.561.8505

American Association of Certified Orthoptists

www.orthoptics.org

5
Figure 1. Red reflex examination. Used with permission of Alfred G. Smith, MD, ©1991.